SCHEMBL485024

SCHEMBL485024

N#Cc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc3c(c1)C(NC(=O)c1cccc(Cl)c1Cl)CC3)C2

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 4/20 0.42
TAS1R1 Q7RTX1 4/20 0.42
TAS1R2 Q8TE23 4/20 0.42
AR P10275 5/20 0.38
ACKR3 P25106 1/20 0.36
CYP2D6 P10635 3/20 0.36
USP2 O75604 2/20 0.36
CYP3A4 P08684 2/20 0.36
DRD4 P21917 1/20 0.36
CXCR3 P49682 1/20 0.35
CYP1A2 P05177 1/20 0.35
HPGD P15428 1/20 0.35
MCHR1 Q99705 1/20 0.35
CCR8 P51685 1/20 0.34
KCNH2 Q12809 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484329 0.95 TAS1R3 (0.42) TAS1R3TAS1R1TAS1R2ARACKR3
SCHEMBL485059 0.91 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2ARCYP2D6
SCHEMBL484287 0.89 AR (0.39) TAS1R3TAS1R1TAS1R2ARACKR3
SCHEMBL485343 0.89 CYP2D6 (0.40) TAS1R3TAS1R1TAS1R2ARCYP2D6
SCHEMBL484813 0.88 USP2 (0.39) ARCYP2D6USP2CYP3A4CYP1A2
SCHEMBL484832 0.85 ACHE (0.42) TAS1R3TAS1R1TAS1R2ACKR3CYP2D6
SCHEMBL484491 0.85 CYP2D6 (0.44) TAS1R3TAS1R1TAS1R2ACKR3CYP2D6
SCHEMBL484732 0.84 CYP3A4 (0.48) CYP2D6USP2CYP3A4CYP1A2HPGD
SCHEMBL484584 0.84 CYP3A4 (0.43) TAS1R3TAS1R1TAS1R2ACKR3CYP2D6
SCHEMBL484604 0.84 ALPI (0.40) TAS1R3TAS1R1TAS1R2ACKR3CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN TAS1R3 339/4885TAS1R1 107/4885TAS1R2 282/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN TAS1R3 339/4885TAS1R1 107/4885TAS1R2 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.